Viewing Study NCT01344304

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-06-04 @ 9:00 PM
Study NCT ID: NCT01344304
Status: COMPLETED
Last Update Posted: 2021-02-26
First Post: 2011-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial
Sponsor: Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None aprepitant therapy View
None fosaprepitant therapy View
None 5HT3-receptor antagonist View
None dexamethasone View
None colorectal cancer View
None FOLFOX View
None XELOX View
None SOX View